|
| Surgery + Chemotherapy | Surgery + Chemotherapy + Radiotherapy | Chemotherapy + Radiotherapy | Chemotherapy | Chemotherapy + Radiotherapy + Targeted therapy |
| Target lesions |
|
|
|
|
|
| Baseline | 17 | 4 | 3 | 43 | 7 |
| 1st assessment | 14 | 3 | 2 | 38 | 3 |
| 2nd assessment | 12 | 3 | 2 | 33 | 3 |
| Non-target lesions |
|
|
|
|
|
| Baseline | 16 | 3 | 2 | 13 | 2 |
| 1st assessment | 12 | 2 | 0 | 11 | 2 |
| 2nd assessment | 12 | 1 | 1 | 6 | 1 |
| New lesions |
|
|
|
|
|
| 1st assessment | 2 | 1 | 2 | 5 | 1 |
| 2nd assessment | 19 | 2 | 2 | 5 | 1 |